Loading…
Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial
Cortes, Jorge E., Kim, Dong-Wook, Pinilla-Ibarz, Javier, le Coutre, Philipp D., Paquette, Ronald, Chuah, Charles, Nicolini, Franck E., Apperley, Jane F., Khoury, H. Jean, Talpaz, Moshe, DeAngelo, Daniel J., Abruzzese, Elisabetta, Rea, Delphine, Baccarani, Michele, Müller, Martin C., Gambacorti-Passerini, Carlo, Lustgarten, Stephanie, Rivera, Victor M., Haluska, Frank G., Guilhot, François, Deininger, Michael W., Hochhaus, Andreas, Hughes, Timothy P., Shah, Neil P., Kantarjian, Hagop M.
Published in Blood (26.07.2018)
Published in Blood (26.07.2018)
Get full text
Journal Article
Loading…
Loading…
Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)
Hughes, Timothy P., Hochhaus, Andreas, Branford, Susan, Müller, Martin C., Kaeda, Jaspal S., Foroni, Letizia, Druker, Brian J., Guilhot, François, Larson, Richard A., O'Brien, Stephen G., Rudoltz, Marc S., Mone, Manisha, Wehrle, Elisabeth, Modur, Vijay, Goldman, John M., Radich, Jerald P.
Published in Blood (11.11.2010)
Published in Blood (11.11.2010)
Get full text
Journal Article
Loading…
Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States
Padula, William V., Larson, Richard A., Dusetzina, Stacie B., Apperley, Jane F., Hehlmann, Rudiger, Baccarani, Michele, Eigendorff, Ekkehard, Guilhot, Joelle, Guilhot, Francois, Mahon, Francois-Xavier, Martinelli, Giovanni, Mayer, Jiri, Müller, Martin C., Niederwieser, Dietger, Saussele, Susanne, Schiffer, Charles A., Silver, Richard T., Simonsson, Bengt, Conti, Rena M.
Published in JNCI : Journal of the National Cancer Institute (01.07.2016)
Published in JNCI : Journal of the National Cancer Institute (01.07.2016)
Get full text
Journal Article
Loading…
Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia
Hehlmann, Rüdiger, Lauseker, Michael, Jung-Munkwitz, Susanne, Leitner, Armin, Müller, Martin C., Pletsch, Nadine, Proetel, Ulrike, Haferlach, Claudia, Schlegelberger, Brigitte, Balleisen, Leopold, Hänel, Mathias, Pfirrmann, Markus, Krause, Stefan W., Nerl, Christoph, Pralle, Hans, Gratwohl, Alois, Hossfeld, Dieter K., Hasford, Joerg, Hochhaus, Andreas, Saußele, Susanne
Published in Journal of clinical oncology (20.04.2011)
Published in Journal of clinical oncology (20.04.2011)
Get full text
Journal Article
Loading…
Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations
Müller, Martin C., Cortes, Jorge E., Kim, Dong-Wook, Druker, Brian J., Erben, Philipp, Pasquini, Ricardo, Branford, Susan, Hughes, Timothy P., Radich, Jerald P., Ploughman, Lynn, Mukhopadhyay, Jaydip, Hochhaus, Andreas
Published in Blood (03.12.2009)
Published in Blood (03.12.2009)
Get full text
Journal Article
Loading…
The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis
Godavarthy, Parimala Sonika, Kumar, Rahul, Herkt, Stefanie C., Pereira, Raquel S., Hayduk, Nina, Weissenberger, Eva S., Aggoune, Djamel, Manavski, Yosif, Lucas, Tina, Pan, Kuan-Ting, Voutsinas, Jenna M., Wu, Qian, Müller, Martin C., Saussele, Susanne, Oellerich, Thomas, Oehler, Vivian G., Lausen, Joern, Krause, Daniela S.
Published in Haematologica (Roma) (01.01.2020)
Published in Haematologica (Roma) (01.01.2020)
Get full text
Journal Article
Loading…
Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia
Soverini, Simona, Branford, Susan, Nicolini, Franck E., Talpaz, Moshe, Deininger, Michael W.N., Martinelli, Giovanni, Müller, Martin C., Radich, Jerald P., Shah, Neil P.
Published in Leukemia research (01.01.2014)
Published in Leukemia research (01.01.2014)
Get full text
Journal Article
Loading…
Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
Hughes, Timothy, Saglio, Giuseppe, Branford, Susan, Soverini, Simona, Kim, Dong-Wook, Müller, Martin C., Martinelli, Giovanni, Cortes, Jorge, Beppu, Lan, Gottardi, Enrico, Kim, Dongho, Erben, Philipp, Shou, Yaping, Haque, Ariful, Gallagher, Neil, Radich, Jerald, Hochhaus, Andreas
Published in Journal of clinical oncology (01.09.2009)
Published in Journal of clinical oncology (01.09.2009)
Get full text
Journal Article
Loading…
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials
Branford, Susan, Fletcher, Linda, Cross, Nicholas C.P., Müller, Martin C., Hochhaus, Andreas, Kim, Dong-Wook, Radich, Jerald P., Saglio, Giuseppe, Pane, Fabrizio, Kamel-Reid, Suzanne, Wang, Y. Lynn, Press, Richard D., Lynch, Kevin, Rudzki, Zbigniew, Goldman, John M., Hughes, Timothy
Published in Blood (15.10.2008)
Published in Blood (15.10.2008)
Get full text
Journal Article
Loading…
Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells
Bolton-Gillespie, Elisabeth, Schemionek, Mirle, Klein, Hans-Ulrich, Flis, Sylwia, Hoser, Grazyna, Lange, Thoralf, Nieborowska-Skorska, Margaret, Maier, Jacqueline, Kerstiens, Linda, Koptyra, Mateusz, Müller, Martin C., Modi, Hardik, Stoklosa, Tomasz, Seferynska, Ilona, Bhatia, Ravi, Holyoake, Tessa L., Koschmieder, Steffen, Skorski, Tomasz
Published in Blood (16.05.2013)
Published in Blood (16.05.2013)
Get full text
Journal Article
Loading…
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
Hurtz, Christian, Hatzi, Katerina, Cerchietti, Leandro, Braig, Melanie, Park, Eugene, Kim, Yong-mi, Herzog, Sebastian, Ramezani-Rad, Parham, Jumaa, Hassan, Müller, Martin C., Hofmann, Wolf-Karsten, Hochhaus, Andreas, Ye, B. Hilda, Agarwal, Anupriya, Druker, Brian J., Shah, Neil P., Melnick, Ari M., Müschen, Markus
Published in The Journal of experimental medicine (24.10.2011)
Published in The Journal of experimental medicine (24.10.2011)
Get full text
Journal Article
Loading…
Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid Leukemia
Burchert, Andreas, Müller, Martin C., Kostrewa, Philippe, Erben, Philipp, Bostel, Tilman, Liebler, Simone, Hehlmann, Rüdiger, Neubauer, Andreas, Hochhaus, Andreas
Published in Journal of clinical oncology (10.03.2010)
Published in Journal of clinical oncology (10.03.2010)
Get full text
Journal Article
Loading…
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV
Saussele, Susanne, Lauseker, Michael, Gratwohl, Alois, Beelen, Dietrich W., Bunjes, Donald, Schwerdtfeger, Rainer, Kolb, Hans-Jochem, Ho, Anthony D., Falge, Christiane, Holler, Ernst, Schlimok, Günter, Zander, Axel R., Arnold, Renate, Kanz, Lothar, Dengler, Robert, Haferlach, Claudia, Schlegelberger, Brigitte, Pfirrmann, Markus, Müller, Martin C., Schnittger, Susanne, Leitner, Armin, Pletsch, Nadine, Hochhaus, Andreas, Hasford, Joerg, Hehlmann, Rüdiger, for the German CML Study Group
Published in Blood (11.03.2010)
Published in Blood (11.03.2010)
Get full text
Journal Article
Loading…
Model-based decision rules reduce the risk of molecular relapse after cessation of tyrosine kinase inhibitor therapy in chronic myeloid leukemia
Horn, Matthias, Glauche, Ingmar, Müller, Martin C., Hehlmann, Rüdiger, Hochhaus, Andreas, Loeffler, Markus, Roeder, Ingo
Published in Blood (10.01.2013)
Published in Blood (10.01.2013)
Get full text
Journal Article
Loading…
Potent, transient inhibition of BCR-ABL with dasatinib 100 mg daily achieves rapid and durable cytogenetic responses and high transformation-free survival rates in chronic phase chronic myeloid leukemia patients with resistance, suboptimal response or intolerance to imatinib
Shah, N. P., Kim, D.-W., Kantarjian, H., Rousselot, P., Llacer, P. E. D., Enrico, A., Vela-Ojeda, J., Silver, R. T., Khoury, H. J., Muller, M. C., Lambert, A., Matloub, Y., Hochhaus, A.
Published in Haematologica (Roma) (01.02.2010)
Published in Haematologica (Roma) (01.02.2010)
Get full text
Journal Article
Loading…
Initial Molecular Response at 3 Months May Predict Both Response and Event-Free Survival at 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia in Chronic Phase Treated With Nilotinib
Branford, Susan, Kim, Dong-Wook, Soverini, Simona, Haque, Ariful, Shou, Yaping, Woodman, Richard C., Kantarjian, Hagop M., Martinelli, Giovanni, Radich, Jerald P., Saglio, Giuseppe, Hochhaus, Andreas, Hughes, Timothy P., Müller, Martin C.
Published in Journal of clinical oncology (10.12.2012)
Published in Journal of clinical oncology (10.12.2012)
Get full text
Journal Article
Loading…
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA
White, Helen E., Matejtschuk, Paul, Rigsby, Peter, Gabert, Jean, Lin, Feng, Lynn Wang, Y., Branford, Susan, Müller, Martin C., Beaufils, Nathalie, Beillard, Emmanuel, Colomer, Dolors, Dvorakova, Dana, Ehrencrona, Hans, Goh, Hyun-Gyung, El Housni, Hakim, Jones, Dan, Kairisto, Veli, Kamel-Reid, Suzanne, Kim, Dong-Wook, Langabeer, Stephen, Ma, Edmond S.K., Press, Richard D., Romeo, Giuliana, Wang, Lihui, Zoi, Katerina, Hughes, Timothy, Saglio, Giuseppe, Hochhaus, Andreas, Goldman, John M., Metcalfe, Paul, Cross, Nicholas C.P.
Published in Blood (25.11.2010)
Published in Blood (25.11.2010)
Get full text
Journal Article
Loading…
Loading…
Establishment and Validation of Analytical Reference Panels for the Standardization of Quantitative BCR-ABL1 Measurements on the International Scale
White, Helen E, Hedges, John, Bendit, Israel, Branford, Susan, Colomer, Dolors, Hochhaus, Andreas, Hughes, Timothy, Kamel-Reid, Suzanne, Kim, Dong-Wook, Modur, Vijay, Müller, Martin C, Pagnano, Katia B, Pane, Fabrizio, Radich, Jerry, Cross, Nicholas CP, Labourier, Emmanuel
Published in Clinical chemistry (Baltimore, Md.) (01.06.2013)
Published in Clinical chemistry (Baltimore, Md.) (01.06.2013)
Get full text
Journal Article